| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CAI
Caris Life Sciences, Inc.
|
Jul 06, 2026 | BUY |
Strong Buy
+65.7% avg upside
20 analysts
|
$25.00
47.07% Upside
|
-4.6% |
|
TMO
Thermo Fisher
|
Jul 06, 2026 | BUY |
Strong Buy
+11.5% avg upside
38 analysts
|
$570.00
8.14% Upside
|
+1.8% |
|
WAT
Waters
|
Jul 06, 2026 | BUY |
Strong Buy
+0.2% avg upside
30 analysts
|
$410.00
8.86% Upside
|
-0.7% |
|
ZBH
Zimmer Biomet Holdings
|
Jul 06, 2026 | BUY |
Buy
+21.9% avg upside
38 analysts
|
$110.00
20.42% Upside
|
+1.8% |
|
PEN
Penumbra
|
Jul 06, 2026 | BUY |
Buy
+3.9% avg upside
23 analysts
|
$320.00
0.52% Upside
|
-0.2% |
|
IRTC
Irhythm Technologies
|
Jul 06, 2026 | BUY |
Strong Buy
+44.9% avg upside
19 analysts
|
$150.00
29.07% Upside
|
-7.9% |
|
GH
Guardant Health
|
Jul 06, 2026 | BUY |
Strong Buy
-12.2% avg upside
31 analysts
|
$200.00
25.05% Upside
|
-5.2% |
|
TWST
Twist Bioscience
|
Jul 06, 2026 | HOLD |
Strong Buy
-17.7% avg upside
14 analysts
|
$102.00
12.54% Upside
|
-9.3% |
|
AVTR
Avantor
|
Jul 06, 2026 | HOLD |
Buy
+39.2% avg upside
26 analysts
|
$10.50
1.04% Upside
|
+0.2% |
|
BLCO
Bausch + Lomb Corporation
|
Jul 06, 2026 | HOLD |
Buy
+20.9% avg upside
19 analysts
|
$17.00
4.77% Upside
|
-2.6% |
|
ABT
Abbott Laboratories
|
Jul 06, 2026 | BUY |
Strong Buy
+24.2% avg upside
36 analysts
|
$112.00
19.18% Upside
|
-1.8% |
|
A
Agilent
|
Jul 06, 2026 | BUY |
Strong Buy
+10.6% avg upside
33 analysts
|
$148.00
10.16% Upside
|
+2.3% |
|
BAX
Baxter International
|
Jul 06, 2026 | BUY |
Hold
+32.1% avg upside
23 analysts
|
$24.00
6.10% Upside
|
+0.0% |
|
BDX
Becton Dickinson
|
Jul 06, 2026 | BUY |
Buy
+28.4% avg upside
25 analysts
|
$180.00
18.38% Upside
|
-2.3% |
|
BSX
Boston Scientific
|
Jul 06, 2026 | BUY |
Strong Buy
+69.5% avg upside
38 analysts
|
$65.00
45.17% Upside
|
+0.4% |
|
ENOV
Enovis
|
Jul 06, 2026 | BUY |
Strong Buy
+167.9% avg upside
37 analysts
|
$32.00
24.31% Upside
|
· |
|
DHR
Danaher
|
Jul 06, 2026 | BUY |
Strong Buy
+8.5% avg upside
45 analysts
|
$230.00
15.57% Upside
|
+2.8% |
|
EW
Edwards Lifesciences
|
Jul 06, 2026 | BUY |
Strong Buy
+6.7% avg upside
34 analysts
|
$100.00
8.50% Upside
|
-4.4% |
|
ILMN
Illumina
|
Jul 06, 2026 | BUY |
Buy
-19.1% avg upside
30 analysts
|
$200.00
5.11% Upside
|
-2.1% |
|
ISRG
Intuitive Surgical
|
Jul 06, 2026 | HOLD |
Strong Buy
+30.3% avg upside
36 analysts
|
$430.00
5.66% Upside
|
-6.0% |
|
MDT
Medtronic
|
Jul 06, 2026 | BUY |
Buy
+15.5% avg upside
38 analysts
|
$105.00
25.24% Upside
|
+0.9% |
|
MTD
Mettler-Toledo
|
Jul 06, 2026 | BUY |
Buy
-9.6% avg upside
18 analysts
|
$1350.00
4.24% Upside
|
+0.0% |
|
RVTY
Revvity
|
Jul 06, 2026 | BUY |
Buy
-5.5% avg upside
23 analysts
|
$125.00
11.29% Upside
|
-0.6% |
|
SYK
Stryker
|
Jul 06, 2026 | BUY |
Strong Buy
+14.5% avg upside
37 analysts
|
$350.00
6.13% Upside
|
+1.6% |
|
PRCT
PROCEPT BioRobotics
|
Jun 24, 2026 | BUY |
Buy
+78.2% avg upside
17 analysts
|
$30.00
43.69% Upside
|
+1.7% |
|
NVCR
NovoCure
|
May 01, 2026 | BUY |
Strong Buy
+200.0% avg upside
11 analysts
|
$20.00
22.67% Upside
|
+5.8% |
|
GEHC
GE Healthcare Technologies Inc
|
Apr 30, 2026 | BUY |
Buy
+27.0% avg upside
22 analysts
|
$80.00
23.68% Upside
|
+6.3% |
|
AZTA
Azenta
|
Apr 06, 2026 | BUY |
Buy
+84.9% avg upside
13 analysts
|
$35.00
38.02% Upside
|
+8.5% |
|
WST
West Pharmaceutical Services
|
Feb 03, 2026 | BUY |
Strong Buy
+0.7% avg upside
17 analysts
|
$320.00
9.59% Downside
|
+34.1% |
|
OSUR
Orasure Technologies
|
May 19, 2025 | HOLD |
Buy
+97.9% avg upside
11 analysts
|
$3.00
30.08% Downside
|
+17.1% |
|
MLAB
Mesa Laboratories
|
Nov 12, 2024 | BUY |
Buy
+47.5% avg upside
5 analysts
|
$150.00
56.91% Upside
|
-28.5% |
|
HYPR
Hyperfine
|
May 12, 2023 | BUY |
Strong Buy
+93.3% avg upside
7 analysts
|
$2.50
129.39% Upside
|
-44.8% |
|
CEG
Constellation Energy Corporation
|
Nov 09, 2022 | BUY |
Strong Buy
+34.2% avg upside
30 analysts
|
$93.00
62.93% Downside
|
+39.7% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.